Evidence map›Paper›PMID 37253751›Full record

ArticleNature communications2023

Allosteric regulation of the 20S proteasome by the Catalytic Core Regulators (CCRs) family.

Fanindra Kumar Deshmukh, Gili Ben-Nissan, Maya A Olshina, Maria G Füzesi-Levi, Caley Polkinghorn, Galina Arkind, Yegor Leushkin, Irit Fainer, Sarel J Fleishman, Dan Tawfik and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Tracking proteasome degradation: A cross-organ analysis via intact degradomics mass spectrometry.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Bortezomib Inhibits Open Configurations of the 20S Proteasome.Journal of the American Society for Mass Spectrometry · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Fanindra Kumar DeshmukhDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.ORCID 0000-0003-1696-697X
Gili Ben-NissanDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Maya A OlshinaDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Maria G Füzesi-LeviDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Caley PolkinghornDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Galina ArkindDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Yegor LeushkinDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Irit FainerDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Sarel J FleishmanDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.ORCID 0000-0003-3177-7560
Dan TawfikDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.ORCID 0000-0002-5914-8240
Michal SharonDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel. michal.sharon@weizmann.ac.il.ORCID 0000-0003-3933-0595
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controlled degradation of proteins is necessary for ensuring their abundance and sustaining a healthy and accurately functioning proteome. One of the degradation routes involves the uncapped 20S proteasome, which cleaves proteins with a partially unfolded region, including those that are damaged or contain intrinsically disordered regions. This degradation route is tightly controlled by a recently discovered family of proteins named Catalytic Core Regulators (CCRs). Here, we show that CCRs function through an allosteric mechanism, coupling the physical binding of the PSMB4 β-subunit with attenuation of the complex's three proteolytic activities. In addition, by dissecting the structural properties that are required for CCR-like function, we could recapitulate this activity using a designed protein that is half the size of natural CCRs. These data uncover an allosteric path that does not involve the proteasome's enzymatic subunits but rather propagates through the non-catalytic subunit PSMB4. This way of 20S proteasome-specific attenuation opens avenues for decoupling the 20S and 26S proteasome degradation pathways as well as for developing selective 20S proteasome inhibitors.

Indexed as

Proteasome Endopeptidase ComplexProteomeAllosteric RegulationCatalytic DomainProteolysisProteasome Endopeptidase ComplexProteome

Identifiers

PMID37253751
PMCPMC10229617
OpenAlexW4378781096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.